Evaluation of the TGS TA system for the detection of anti-Toxoplasma antibodies

<em>Background and aims.</em> The aim of the present study was to evaluate the new chemiluminescence TGS TA system of Technogenetics (Milan, Italy) for detecting anti-Toxoplasma IgG and IgM antibodies and IgG avidity. The TGS TA system was compared with our chemiluminescence routinely us...

Full description

Bibliographic Details
Main Authors: Olivia Arpino, Annalisa Cianflone, Maria Teresa Manco, Alessia Paganini, Massimo De Paschale, Carlo Agrappi, Paola Mirri, Pierangelo Clerici
Format: Article
Language:English
Published: PAGEPress Publications 2017-03-01
Series:Microbiologia Medica
Subjects:
IgM
IgG
Online Access:http://www.pagepressjournals.org/index.php/mm/article/view/6583
id doaj-440537a68f474c0297a66b082c595850
record_format Article
spelling doaj-440537a68f474c0297a66b082c5958502020-11-25T02:30:54ZengPAGEPress PublicationsMicrobiologia Medica 2280-64232017-03-0132110.4081/mm.2017.65835200Evaluation of the TGS TA system for the detection of anti-Toxoplasma antibodiesOlivia Arpino0Annalisa Cianflone1Maria Teresa Manco2Alessia Paganini3Massimo De Paschale4Carlo Agrappi5Paola Mirri6Pierangelo Clerici7Microbiology Unit, Legnano Hospital, ASST Ovest Milanese, LegnanoMicrobiology Unit, Legnano Hospital, ASST Ovest Milanese, LegnanoMicrobiology Unit, Legnano Hospital, ASST Ovest Milanese, LegnanoMicrobiology Unit, Legnano Hospital, ASST Ovest Milanese, LegnanoMicrobiology Unit, Legnano Hospital, ASST Ovest Milanese, LegnanoMicrobiology Unit, Legnano Hospital, ASST Ovest Milanese, LegnanoMicrobiology Unit, Legnano Hospital, ASST Ovest Milanese, LegnanoMicrobiology Unit, Legnano Hospital, ASST Ovest Milanese, Legnano<em>Background and aims.</em> The aim of the present study was to evaluate the new chemiluminescence TGS TA system of Technogenetics (Milan, Italy) for detecting anti-Toxoplasma IgG and IgM antibodies and IgG avidity. The TGS TA system was compared with our chemiluminescence routinely used system, LIAISON XL, supplied by Diasorin (Saluggia, Italy), for the detection of IgG and IgM antibodies. Only in positive IgM samples (retrospective study) and for the IgG avidity (if existent), TGS TA system was compared to an Enzyme Linked Fluorescent Assay (ELFA) test (VIDAS, BioMérieux, Marcy-l’Étoile, France). <br /><em>Materials and methods</em>. Three hundred and one sera samples, from women who came to our centre for the routine follow up pregnancy, were examined with the TGS TA system and divided in 3 groups according to IgG and IgM screening LIAISON XL tests: 106 were non-immune women (Group 1), 100 were pregnant with past infection (Group 2) and 95 were pregnant with positive or equivocal IgM (82 with positive IgG and 13 with negative IgG) (Group 3). <br /><em>Results</em>. The overall concordance of the IgG results between LIAISON XL and TGS TA was 99.3%: 100% in Group 1, 98% in Group 2 and 100% in Group 3. The overall concordance of the IgM results between LIAISON XL and TGS TA was 93.9%: 100% in Group 1, 94% in Group 2 and 82.8% in Group 3. In Group 3, the concordance between the results of the IgG avidity with the ELFA and TGS TA tests was 81.7%. Comparing the clinical diagnosis obtained with our protocol and that of the TGS TA system, the overall concordance was 92.7%: 100% in Group 1, 92.0% in Group 2 and 78.9% in Group 3. <br /><em>Conclusions</em>. The overall concordance of IgG antibodies is excellent for both protocols while for IgM antibodies is very high in the first group and lower in the third group, due to the presence of non-specific IgM subjects in this group. The TGS TA avidity test seems to predict ealier the maturation of the IgG compared to the ELFA test since many samples with low avidity with the ELFA were seen with moderate avidity with TGS TA and all those with borderline avidity with the ELFA were seen with high avidity with TGS TA. This system shows to be a valuable tool with overall good clinical correlation and able to clearly identify nonspecific subjects, those with a non-recent infection.http://www.pagepressjournals.org/index.php/mm/article/view/6583ToxoplasmaPregnancyIgMIgGAvidity
collection DOAJ
language English
format Article
sources DOAJ
author Olivia Arpino
Annalisa Cianflone
Maria Teresa Manco
Alessia Paganini
Massimo De Paschale
Carlo Agrappi
Paola Mirri
Pierangelo Clerici
spellingShingle Olivia Arpino
Annalisa Cianflone
Maria Teresa Manco
Alessia Paganini
Massimo De Paschale
Carlo Agrappi
Paola Mirri
Pierangelo Clerici
Evaluation of the TGS TA system for the detection of anti-Toxoplasma antibodies
Microbiologia Medica
Toxoplasma
Pregnancy
IgM
IgG
Avidity
author_facet Olivia Arpino
Annalisa Cianflone
Maria Teresa Manco
Alessia Paganini
Massimo De Paschale
Carlo Agrappi
Paola Mirri
Pierangelo Clerici
author_sort Olivia Arpino
title Evaluation of the TGS TA system for the detection of anti-Toxoplasma antibodies
title_short Evaluation of the TGS TA system for the detection of anti-Toxoplasma antibodies
title_full Evaluation of the TGS TA system for the detection of anti-Toxoplasma antibodies
title_fullStr Evaluation of the TGS TA system for the detection of anti-Toxoplasma antibodies
title_full_unstemmed Evaluation of the TGS TA system for the detection of anti-Toxoplasma antibodies
title_sort evaluation of the tgs ta system for the detection of anti-toxoplasma antibodies
publisher PAGEPress Publications
series Microbiologia Medica
issn 2280-6423
publishDate 2017-03-01
description <em>Background and aims.</em> The aim of the present study was to evaluate the new chemiluminescence TGS TA system of Technogenetics (Milan, Italy) for detecting anti-Toxoplasma IgG and IgM antibodies and IgG avidity. The TGS TA system was compared with our chemiluminescence routinely used system, LIAISON XL, supplied by Diasorin (Saluggia, Italy), for the detection of IgG and IgM antibodies. Only in positive IgM samples (retrospective study) and for the IgG avidity (if existent), TGS TA system was compared to an Enzyme Linked Fluorescent Assay (ELFA) test (VIDAS, BioMérieux, Marcy-l’Étoile, France). <br /><em>Materials and methods</em>. Three hundred and one sera samples, from women who came to our centre for the routine follow up pregnancy, were examined with the TGS TA system and divided in 3 groups according to IgG and IgM screening LIAISON XL tests: 106 were non-immune women (Group 1), 100 were pregnant with past infection (Group 2) and 95 were pregnant with positive or equivocal IgM (82 with positive IgG and 13 with negative IgG) (Group 3). <br /><em>Results</em>. The overall concordance of the IgG results between LIAISON XL and TGS TA was 99.3%: 100% in Group 1, 98% in Group 2 and 100% in Group 3. The overall concordance of the IgM results between LIAISON XL and TGS TA was 93.9%: 100% in Group 1, 94% in Group 2 and 82.8% in Group 3. In Group 3, the concordance between the results of the IgG avidity with the ELFA and TGS TA tests was 81.7%. Comparing the clinical diagnosis obtained with our protocol and that of the TGS TA system, the overall concordance was 92.7%: 100% in Group 1, 92.0% in Group 2 and 78.9% in Group 3. <br /><em>Conclusions</em>. The overall concordance of IgG antibodies is excellent for both protocols while for IgM antibodies is very high in the first group and lower in the third group, due to the presence of non-specific IgM subjects in this group. The TGS TA avidity test seems to predict ealier the maturation of the IgG compared to the ELFA test since many samples with low avidity with the ELFA were seen with moderate avidity with TGS TA and all those with borderline avidity with the ELFA were seen with high avidity with TGS TA. This system shows to be a valuable tool with overall good clinical correlation and able to clearly identify nonspecific subjects, those with a non-recent infection.
topic Toxoplasma
Pregnancy
IgM
IgG
Avidity
url http://www.pagepressjournals.org/index.php/mm/article/view/6583
work_keys_str_mv AT oliviaarpino evaluationofthetgstasystemforthedetectionofantitoxoplasmaantibodies
AT annalisacianflone evaluationofthetgstasystemforthedetectionofantitoxoplasmaantibodies
AT mariateresamanco evaluationofthetgstasystemforthedetectionofantitoxoplasmaantibodies
AT alessiapaganini evaluationofthetgstasystemforthedetectionofantitoxoplasmaantibodies
AT massimodepaschale evaluationofthetgstasystemforthedetectionofantitoxoplasmaantibodies
AT carloagrappi evaluationofthetgstasystemforthedetectionofantitoxoplasmaantibodies
AT paolamirri evaluationofthetgstasystemforthedetectionofantitoxoplasmaantibodies
AT pierangeloclerici evaluationofthetgstasystemforthedetectionofantitoxoplasmaantibodies
_version_ 1724827032653660160